Condition (MeSH)
Chilblains
ClinicalTrials.gov lists 7 trials for Chilblains or a narrower condition beneath it. Jinnah Postgraduate Medical Centre has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
7 of the 7 trials are tagged with Chilblains itself; the rest are tagged with a narrower condition beneath it.
When did Chilblains trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2022 | 1 |
| 2020 | 5 |
| 2016 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 7 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Chilblains trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 3 |
| Observational | 4 |
How many Chilblains trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 6 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Chilblains trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Jinnah Postgraduate Medical Centre | 1 |
Which publications cover Chilblains? (6)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Chilblains during lockdown are associated with household exposure to SARS-CoV-2: a multicentre case-control study. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022 | Yes |
| Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic. | JAMA dermatology | 2021 | Yes |
| Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy. | The Lancet. Infectious diseases | 2021 | Yes |
| Long-term Outcome of Chilblains Associated with SARS-CoV-2. | Acta dermato-venereologica | 2021 | Yes |
| Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries. | Journal of the American Academy of Dermatology | 2020 | Yes |
Showing 5 of 6 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.